Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.

Abstract

There is little information on chemotherapy-induced peripheral neuropathy (PN) for community-dwelling patients with cancer. We studied 65,316 patients with breast cancer, 9242 with ovarian cancer, and 86,278 with non-small cell lung cancer from 1991 through 2002 identified from the 16 areas of Surveillance, Epidemiology and End Results. The incidence… (More)
DOI: 10.1097/MJT.0b013e3181a3e50b

Topics

Cite this paper

@article{Nurgalieva2010RiskOC, title={Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.}, author={Zhannat Z Nurgalieva and Rui Xia and C Liu and Keith Dean Burau and Dale S Hardy and Xianglin L. Du}, journal={American journal of therapeutics}, year={2010}, volume={17 2}, pages={148-58} }